These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

733 related articles for article (PubMed ID: 33614651)

  • 1. Epigenetic Landscape of Liquid Biopsy in Colorectal Cancer.
    Rodriguez-Casanova A; Costa-Fraga N; Bao-Caamano A; López-López R; Muinelo-Romay L; Diaz-Lagares A
    Front Cell Dev Biol; 2021; 9():622459. PubMed ID: 33614651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liquid Biopsy and Artificial Intelligence as Tools to Detect Signatures of Colorectal Malignancies: A Modern Approach in Patient's Stratification.
    Ginghina O; Hudita A; Zamfir M; Spanu A; Mardare M; Bondoc I; Buburuzan L; Georgescu SE; Costache M; Negrei C; Nitipir C; Galateanu B
    Front Oncol; 2022; 12():856575. PubMed ID: 35356214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection and clinical significance of circulating tumor cells in colorectal cancer.
    Jiang M; Jin S; Han J; Li T; Shi J; Zhong Q; Li W; Tang W; Huang Q; Zong H
    Biomark Res; 2021 Nov; 9(1):85. PubMed ID: 34798902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of liquid biopsies in colorectal cancer.
    Wills B; Gorse E; Lee V
    Curr Probl Cancer; 2018 Nov; 42(6):593-600. PubMed ID: 30268335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating Tumor Cells and Cell-free Nucleic Acids as Biomarkers in Colorectal Cancer.
    Pourali G; Khalili-Tanha G; Nazari E; Maftooh M; Nassiri M; Hassanian SM; Mobarhan MG; Khazaei M; Ferns G; Avan A
    Curr Pharm Des; 2023; 29(10):748-765. PubMed ID: 36892023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liquid biopsy approaches and immunotherapy in colorectal cancer for precision medicine: Are we there yet?
    Mirza S; Bhadresha K; Mughal MJ; McCabe M; Shahbazi R; Ruff P; Penny C
    Front Oncol; 2022; 12():1023565. PubMed ID: 36686736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as a Liquid Biopsy Marker in Colorectal Cancer.
    Heidrich I; Abdalla TSA; Reeh M; Pantel K
    Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Applications of Liquid Biopsy in Colorectal Cancer Screening: Current Challenges and Future Perspectives.
    Galoș D; Gorzo A; Balacescu O; Sur D
    Cells; 2022 Nov; 11(21):. PubMed ID: 36359889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential Utility of Liquid Biopsy as a Diagnostic and Prognostic Tool for the Assessment of Solid Tumors: Implications in the Precision Oncology.
    Mathai RA; Vidya RVS; Reddy BS; Thomas L; Udupa K; Kolesar J; Rao M
    J Clin Med; 2019 Mar; 8(3):. PubMed ID: 30889786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating biomarkers for early detection and clinical management of colorectal cancer.
    Marcuello M; Vymetalkova V; Neves RPL; Duran-Sanchon S; Vedeld HM; Tham E; van Dalum G; Flügen G; Garcia-Barberan V; Fijneman RJ; Castells A; Vodicka P; Lind GE; Stoecklein NH; Heitzer E; Gironella M
    Mol Aspects Med; 2019 Oct; 69():107-122. PubMed ID: 31189073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liquid Biopsy in Colorectal Carcinoma: Clinical Applications and Challenges.
    Kolenčík D; Shishido SN; Pitule P; Mason J; Hicks J; Kuhn P
    Cancers (Basel); 2020 May; 12(6):. PubMed ID: 32471160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating microRNAs as Promising Biomarkers in Colorectal Cancer.
    Rapado-González Ó; Álvarez-Castro A; López-López R; Iglesias-Canle J; Suárez-Cunqueiro MM; Muinelo-Romay L
    Cancers (Basel); 2019 Jun; 11(7):. PubMed ID: 31252648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early Detection, Precision Treatment, Recurrence Monitoring: Liquid Biopsy Transforms Colorectal Cancer Therapy.
    Raval H; Bhattacharya S
    Curr Cancer Drug Targets; 2024 Apr; ():. PubMed ID: 38623975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The liquid biopsy in the management of colorectal cancer patients: Current applications and future scenarios.
    Normanno N; Cervantes A; Ciardiello F; De Luca A; Pinto C
    Cancer Treat Rev; 2018 Nov; 70():1-8. PubMed ID: 30053724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of minimally invasive biomarkers for the diagnosis and prognosis of hepatocellular carcinoma.
    Trevisan França de Lima L; Broszczak D; Zhang X; Bridle K; Crawford D; Punyadeera C
    Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188451. PubMed ID: 33065194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNAs as potential liquid biopsy biomarkers in colorectal cancer: A systematic review.
    Toiyama Y; Okugawa Y; Fleshman J; Richard Boland C; Goel A
    Biochim Biophys Acta Rev Cancer; 2018 Dec; 1870(2):274-282. PubMed ID: 29852194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liquid biopsy in colorectal cancer: No longer young, but not yet old.
    Roviello G; Lavacchi D; Antonuzzo L; Catalano M; Mini E
    World J Gastroenterol; 2022 Apr; 28(15):1503-1507. PubMed ID: 35582130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and biological significance of circulating tumor cells, circulating tumor DNA, and exosomes as biomarkers in colorectal cancer.
    Jia S; Zhang R; Li Z; Li J
    Oncotarget; 2017 Aug; 8(33):55632-55645. PubMed ID: 28903450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetics of colorectal cancer: emerging circulating diagnostic and prognostic biomarkers.
    Danese E; Montagnana M
    Ann Transl Med; 2017 Jul; 5(13):279. PubMed ID: 28758105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Current Landscape of Glioblastoma Biomarkers in Body Fluids.
    Zanganeh S; Abbasgholinejad E; Doroudian M; Esmaelizad N; Farjadian F; Benhabbour SR
    Cancers (Basel); 2023 Jul; 15(15):. PubMed ID: 37568620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.